Arianne Theiss
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 16 | 2026 | 430 | 3.980 |
Why?
| | Colitis | 13 | 2026 | 283 | 3.890 |
Why?
| | Mitochondria | 14 | 2026 | 997 | 3.560 |
Why?
| | Inflammatory Bowel Diseases | 13 | 2025 | 352 | 3.180 |
Why?
| | Intestinal Mucosa | 21 | 2026 | 666 | 2.960 |
Why?
| | Paneth Cells | 5 | 2026 | 20 | 2.650 |
Why?
| | Colon | 12 | 2026 | 304 | 1.850 |
Why?
| | Crohn Disease | 5 | 2023 | 250 | 1.840 |
Why?
| | Extracellular Vesicles | 3 | 2025 | 176 | 1.640 |
Why?
| | Colorectal Neoplasms | 5 | 2025 | 874 | 1.600 |
Why?
| | Carcinogenesis | 3 | 2025 | 226 | 1.550 |
Why?
| | STAT3 Transcription Factor | 6 | 2015 | 214 | 1.400 |
Why?
| | Ileitis | 2 | 2023 | 33 | 1.380 |
Why?
| | Benzofurans | 2 | 2020 | 26 | 1.090 |
Why?
| | Colonic Neoplasms | 5 | 2025 | 259 | 1.060 |
Why?
| | Gastrointestinal Microbiome | 4 | 2024 | 769 | 0.970 |
Why?
| | Caco-2 Cells | 12 | 2018 | 80 | 0.930 |
Why?
| | Inflammation | 11 | 2023 | 2919 | 0.910 |
Why?
| | Gastrointestinal Diseases | 2 | 2025 | 220 | 0.880 |
Why?
| | Intestines | 6 | 2023 | 351 | 0.860 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2021 | 1432 | 0.850 |
Why?
| | Intra-Abdominal Fat | 1 | 2025 | 104 | 0.850 |
Why?
| | Epithelial Cells | 7 | 2025 | 1119 | 0.830 |
Why?
| | Obesity | 3 | 2025 | 3131 | 0.810 |
Why?
| | Axin Protein | 2 | 2020 | 18 | 0.800 |
Why?
| | Mice | 32 | 2026 | 18297 | 0.790 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2021 | 1224 | 0.750 |
Why?
| | Mitochondrial Membranes | 1 | 2023 | 40 | 0.740 |
Why?
| | Inflammasomes | 2 | 2021 | 145 | 0.740 |
Why?
| | Antioxidants | 2 | 2021 | 544 | 0.740 |
Why?
| | beta Catenin | 2 | 2025 | 250 | 0.740 |
Why?
| | Autophagy | 4 | 2023 | 290 | 0.710 |
Why?
| | Animals | 38 | 2026 | 38106 | 0.690 |
Why?
| | Fatty Acids | 1 | 2025 | 460 | 0.690 |
Why?
| | Apoptosis | 6 | 2020 | 2439 | 0.670 |
Why?
| | Cytokines | 4 | 2026 | 2081 | 0.650 |
Why?
| | Mice, Inbred C57BL | 15 | 2026 | 6034 | 0.640 |
Why?
| | Intestinal Neoplasms | 1 | 2020 | 31 | 0.640 |
Why?
| | Adipose Tissue | 1 | 2025 | 642 | 0.630 |
Why?
| | Stem Cells | 1 | 2025 | 613 | 0.630 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 167 | 0.600 |
Why?
| | Wnt Proteins | 1 | 2020 | 131 | 0.600 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 211 | 0.540 |
Why?
| | Glutarates | 1 | 2018 | 11 | 0.540 |
Why?
| | Cell Nucleus | 1 | 2020 | 584 | 0.510 |
Why?
| | Mice, Knockout | 10 | 2026 | 3125 | 0.500 |
Why?
| | Signal Transduction | 5 | 2026 | 5246 | 0.490 |
Why?
| | Interleukin-17 | 4 | 2022 | 121 | 0.480 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2025 | 46 | 0.440 |
Why?
| | Dextran Sulfate | 5 | 2018 | 93 | 0.440 |
Why?
| | Colitis, Ulcerative | 4 | 2021 | 143 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2015 | 530 | 0.420 |
Why?
| | Transcription Factors | 4 | 2026 | 1730 | 0.420 |
Why?
| | Humans | 43 | 2026 | 146342 | 0.420 |
Why?
| | Oxidative Stress | 4 | 2025 | 1369 | 0.410 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2023 | 198 | 0.410 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2022 | 14 | 0.400 |
Why?
| | Reactive Oxygen Species | 4 | 2023 | 610 | 0.400 |
Why?
| | NF-E2 Transcription Factor, p45 Subunit | 1 | 2013 | 3 | 0.390 |
Why?
| | Biological Products | 1 | 2016 | 258 | 0.360 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 447 | 0.340 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4580 | 0.330 |
Why?
| | Mice, Transgenic | 6 | 2020 | 2134 | 0.320 |
Why?
| | Heme Oxygenase-1 | 2 | 2025 | 76 | 0.320 |
Why?
| | Homeostasis | 2 | 2026 | 646 | 0.320 |
Why?
| | Immunity, Innate | 3 | 2026 | 844 | 0.300 |
Why?
| | alpha Karyopherins | 1 | 2009 | 10 | 0.300 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 93 | 0.290 |
Why?
| | Stress, Physiological | 1 | 2012 | 450 | 0.280 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2005 | 320 | 0.270 |
Why?
| | Interleukin-6 | 3 | 2007 | 784 | 0.270 |
Why?
| | DNA-Binding Proteins | 2 | 2025 | 1468 | 0.260 |
Why?
| | Biopsy | 3 | 2021 | 1075 | 0.260 |
Why?
| | Nanoparticles | 2 | 2011 | 523 | 0.250 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 377 | 0.250 |
Why?
| | Rectal Prolapse | 1 | 2026 | 25 | 0.240 |
Why?
| | Collagen | 2 | 2005 | 460 | 0.230 |
Why?
| | Magnesium | 1 | 2026 | 155 | 0.230 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 26 | 0.230 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 41 | 0.230 |
Why?
| | Gene Expression Regulation | 4 | 2026 | 2599 | 0.220 |
Why?
| | Growth Hormone | 1 | 2005 | 91 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 134 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 170 | 0.210 |
Why?
| | Antineoplastic Agents | 2 | 2014 | 2219 | 0.210 |
Why?
| | Human Growth Hormone | 1 | 2004 | 46 | 0.210 |
Why?
| | Cell Proliferation | 3 | 2020 | 2502 | 0.210 |
Why?
| | Glycolysis | 1 | 2025 | 342 | 0.200 |
Why?
| | Diet, High-Fat | 1 | 2025 | 267 | 0.190 |
Why?
| | Iron | 1 | 2025 | 359 | 0.190 |
Why?
| | Fibroblasts | 2 | 2005 | 1034 | 0.190 |
Why?
| | Butyrates | 1 | 2023 | 65 | 0.190 |
Why?
| | p21-Activated Kinases | 1 | 2022 | 13 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 203 | 0.180 |
Why?
| | Male | 12 | 2025 | 73396 | 0.180 |
Why?
| | Up-Regulation | 2 | 2021 | 841 | 0.180 |
Why?
| | Cell Survival | 2 | 2018 | 1105 | 0.170 |
Why?
| | Enterocytes | 1 | 2021 | 13 | 0.170 |
Why?
| | RNA, Small Interfering | 3 | 2017 | 633 | 0.170 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1075 | 0.170 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2021 | 18 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 14 | 0.160 |
Why?
| | Promoter Regions, Genetic | 2 | 2026 | 1242 | 0.160 |
Why?
| | Genes, Reporter | 2 | 2013 | 275 | 0.160 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2020 | 3 | 0.160 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 263 | 0.160 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 314 | 0.160 |
Why?
| | Gene Silencing | 2 | 2012 | 200 | 0.160 |
Why?
| | Enterocolitis | 1 | 2020 | 18 | 0.160 |
Why?
| | Energy Metabolism | 1 | 2026 | 930 | 0.160 |
Why?
| | Membrane Proteins | 2 | 2025 | 1130 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 295 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 882 | 0.150 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 84 | 0.140 |
Why?
| | Interleukin-18 | 1 | 2020 | 234 | 0.140 |
Why?
| | Organoids | 1 | 2020 | 143 | 0.140 |
Why?
| | Piperidines | 1 | 2020 | 225 | 0.140 |
Why?
| | Immunity, Mucosal | 1 | 2019 | 97 | 0.130 |
Why?
| | Azoxymethane | 1 | 2018 | 18 | 0.130 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 371 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 429 | 0.130 |
Why?
| | Intercellular Adhesion Molecule-3 | 1 | 2017 | 2 | 0.130 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3545 | 0.130 |
Why?
| | LIM Domain Proteins | 1 | 2017 | 20 | 0.130 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 42 | 0.130 |
Why?
| | Curcuma | 1 | 2017 | 1 | 0.130 |
Why?
| | Oils, Volatile | 1 | 2017 | 5 | 0.130 |
Why?
| | Lipid Metabolism | 1 | 2021 | 533 | 0.130 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 49 | 0.130 |
Why?
| | Blotting, Western | 2 | 2013 | 1177 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 2 | 2010 | 663 | 0.130 |
Why?
| | Female | 9 | 2025 | 79499 | 0.120 |
Why?
| | RNA, Messenger | 4 | 2017 | 2791 | 0.120 |
Why?
| | Green Fluorescent Proteins | 2 | 2010 | 408 | 0.120 |
Why?
| | Fibrosis | 3 | 2017 | 568 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2623 | 0.120 |
Why?
| | Glutathione | 2 | 2009 | 369 | 0.120 |
Why?
| | Myofibroblasts | 1 | 2017 | 149 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 299 | 0.110 |
Why?
| | Ubiquitination | 3 | 2022 | 119 | 0.110 |
Why?
| | Oncogene Protein p21(ras) | 1 | 2015 | 11 | 0.110 |
Why?
| | DNA Methylation | 1 | 2021 | 725 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2014 | 4118 | 0.110 |
Why?
| | Biological Assay | 1 | 2016 | 133 | 0.110 |
Why?
| | Risk | 1 | 2018 | 920 | 0.110 |
Why?
| | Phosphorylation | 2 | 2022 | 1724 | 0.110 |
Why?
| | Neoplasms | 1 | 2011 | 2954 | 0.110 |
Why?
| | Gene Knockdown Techniques | 2 | 2015 | 335 | 0.110 |
Why?
| | NF-kappa B | 2 | 2010 | 674 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 457 | 0.100 |
Why?
| | Interleukin-10 | 2 | 2006 | 310 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2017 | 474 | 0.100 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 7 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 951 | 0.100 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 36 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1211 | 0.100 |
Why?
| | RNA | 2 | 2013 | 926 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2016 | 508 | 0.090 |
Why?
| | Luciferases | 1 | 2013 | 153 | 0.090 |
Why?
| | Phenotype | 1 | 2021 | 3206 | 0.090 |
Why?
| | Protein Binding | 2 | 2020 | 2244 | 0.090 |
Why?
| | Peroxidase | 1 | 2013 | 168 | 0.090 |
Why?
| | Barrett Esophagus | 1 | 2015 | 172 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.090 |
Why?
| | HCT116 Cells | 1 | 2012 | 78 | 0.090 |
Why?
| | Free Radical Scavengers | 1 | 2012 | 81 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2012 | 75 | 0.090 |
Why?
| | Intracellular Space | 1 | 2012 | 64 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2012 | 139 | 0.080 |
Why?
| | Polyethyleneimine | 1 | 2011 | 19 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 307 | 0.080 |
Why?
| | DNA | 2 | 2009 | 1421 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1339 | 0.080 |
Why?
| | Interferon-gamma | 2 | 2026 | 781 | 0.080 |
Why?
| | Time Factors | 4 | 2017 | 7109 | 0.080 |
Why?
| | Th17 Cells | 2 | 2021 | 103 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 290 | 0.080 |
Why?
| | Disease Progression | 1 | 2018 | 2867 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2026 | 1432 | 0.070 |
Why?
| | Adenocarcinoma | 2 | 2009 | 927 | 0.070 |
Why?
| | Protein Carbonylation | 1 | 2009 | 57 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 120 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2009 | 96 | 0.070 |
Why?
| | Gene Expression | 2 | 2020 | 1463 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 443 | 0.070 |
Why?
| | Acute Disease | 1 | 2010 | 1038 | 0.060 |
Why?
| | Cell Line | 1 | 2013 | 2814 | 0.060 |
Why?
| | Keratin-8 | 1 | 2007 | 4 | 0.060 |
Why?
| | Salmonella typhimurium | 1 | 2009 | 194 | 0.060 |
Why?
| | Transcription Initiation Site | 1 | 2007 | 43 | 0.060 |
Why?
| | Sumoylation | 1 | 2026 | 18 | 0.060 |
Why?
| | Keratins | 1 | 2007 | 57 | 0.060 |
Why?
| | Response Elements | 1 | 2007 | 85 | 0.060 |
Why?
| | Transfection | 1 | 2009 | 916 | 0.060 |
Why?
| | Glutathione Transferase | 1 | 2006 | 92 | 0.060 |
Why?
| | Prognosis | 1 | 2014 | 4351 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 11 | 0.060 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 57 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2005 | 58 | 0.060 |
Why?
| | Cecum | 1 | 2005 | 37 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2005 | 197 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 20 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2005 | 105 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 168 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2005 | 76 | 0.060 |
Why?
| | Hepatocytes | 1 | 2026 | 224 | 0.060 |
Why?
| | Heme | 1 | 2025 | 90 | 0.050 |
Why?
| | Homozygote | 1 | 2005 | 197 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2005 | 162 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2006 | 337 | 0.050 |
Why?
| | Polysaccharides | 1 | 2005 | 88 | 0.050 |
Why?
| | Granuloma | 1 | 2005 | 96 | 0.050 |
Why?
| | Joints | 1 | 2005 | 107 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2005 | 391 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2005 | 759 | 0.050 |
Why?
| | Models, Biological | 1 | 2011 | 1761 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 369 | 0.050 |
Why?
| | Drug Interactions | 1 | 2004 | 405 | 0.050 |
Why?
| | Escherichia coli | 1 | 2007 | 832 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2092 | 0.050 |
Why?
| | Perylene | 1 | 2002 | 6 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2838 | 0.050 |
Why?
| | Photochemotherapy | 1 | 2002 | 39 | 0.050 |
Why?
| | Photosensitizing Agents | 1 | 2002 | 42 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2022 | 0.040 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 40 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2021 | 238 | 0.040 |
Why?
| | Citrobacter rodentium | 1 | 2020 | 6 | 0.040 |
Why?
| | Genotype | 1 | 2005 | 1879 | 0.040 |
Why?
| | Calcium | 1 | 2026 | 1181 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 2020 | 43 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 156 | 0.040 |
Why?
| | Chronic Disease | 1 | 2005 | 1827 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 487 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2020 | 339 | 0.030 |
Why?
| | Esophageal Neoplasms | 1 | 2002 | 351 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 441 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2026 | 2012 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 507 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 628 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2921 | 0.030 |
Why?
| | Curcumin | 1 | 2017 | 29 | 0.030 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 356 | 0.030 |
Why?
| | Permeability | 2 | 2007 | 166 | 0.030 |
Why?
| | Rats | 1 | 2005 | 5586 | 0.030 |
Why?
| | Collagen Type I | 1 | 2017 | 144 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 747 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 209 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 137 | 0.030 |
Why?
| | Actins | 1 | 2017 | 422 | 0.030 |
Why?
| | Colonoscopy | 1 | 2017 | 257 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 750 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 931 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1982 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1792 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1014 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 345 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5439 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 4093 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 322 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 340 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8391 | 0.010 |
Why?
| | Aminolevulinic Acid | 1 | 2002 | 4 | 0.010 |
Why?
| | Anthracenes | 1 | 2002 | 31 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1532 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2002 | 141 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2007 | 3647 | 0.010 |
Why?
| | Middle Aged | 2 | 2017 | 36619 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17438 | 0.010 |
Why?
| | Aged | 1 | 2017 | 26432 | 0.010 |
Why?
| | Adult | 1 | 2017 | 41087 | 0.010 |
Why?
|
|
Theiss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|